Recombinant Human p21 Protein, >90% (SDS-PAGE), high purity

Item Number

rp156666

• Product Name: Recombinant Human p21 Protein, >90% (SDS-PAGE), high purity
• Synonyms: CAP20 | CDK-interacting protein 1 | CDKI | CDKN1 | Cdkn1a | CDN1A_HUMAN | CIP1 | Cyclin Dependent Kinase Inhibitor 1A | Cyclin-dependent kinase inhibitor 1 | Cyclin-dependent kinase inhibitor 1A (P21) | DNA Synthesis Inhibitor | Cyclin-dependent kinase in
• Grade: Azide Free, Carrier Free
• Specifications & Purity: Carrier Free, Azide Free, ≥90%(SDS-PAGE)
• Purity: >90% (SDS-PAGE)
• Endotoxin Concentration: ＜1.0 EU/μg
• Expression System: E. coli
• Amino Acids: 1-164 aa
• Sequence: MGHHHHHHMSEPAGDVRQNPCGSKACRRLFGPVDSEQLSRDCDALMAGCIQEARERWNFDFVTETPLEGDFAWERVRGLGLPKLYLPTGPRRGRDELGGGRRPGTSPALLQGTAEEDHVDLSLSCTLVPRSGEQAEGSPGGPGDSQGRKRRQTSMTDFYHSKRRLIFSKRKP
• Protein Tag: N-His
• Predicted molecular weight: 18.1 kDa
• SDS-PAGE: 18.4 kDa, under reducing conditions

Product Description

Purity:>90%, by SDS-PAGE visualized with Coomassie® Blue Staining.
Description：
p21CIP1, also called CIP1 (CDK-interacting protein 1) and CDKN1A, is a 21 kDa Cyclin/Cyclin-dependent kinase (Cdk) inhibitor that blocks cell cycle progression from G1 to S phase in the cell cycle. Because p21 is a transcriptional target of the p53 tumor suppressor, p21 expression increases in cells that contain stabilized p53 due to genotoxic stress exposure. May be the important intermediate by which p53/TP53 mediates its role as an inhibitor of cellular proliferation in response to DNA damage. Binds to and inhibits cyclin-dependent kinase activity, preventing phosphorylation of critical cyclin-dependent kinase substrates and blocking cell cycle progression. Functions in the nuclear localization and assembly of cyclin D-CDK4 complex and promotes its kinase activity towards RB1. At higher stoichiometric ratios, inhibits the kinase activity of the cyclin D-CDK4 complex.